Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

  • There is currently no data for GUS

Experian Trading Update

14 Sep 2006 07:03

GUS PLC14 September 2006 14 September 2006 GUS plc Experian Trading Update Experian, the global information solutions company, which is part of GUS plc, isissuing this update on trading to coincide with the publication of itsprospectus later today. Don Robert, Chief Executive Officer of Experian, said: "We are pleased with the performance of Experian in the first five months of theyear, which continues to show good growth in line with our expectations. Salesgrew by 18%, with organic growth of 7%, reflecting the scale and strength of theExperian business around the world." % change in sales year-on-year for the five months to 31 August 2006+------------------------------+-------------------+-------------------+|Continuing activities only* |At actual exchange | At constant || | rates %# | exchange rates % |+------------------------------+-------------------+-------------------+|Americas | 20 | 20 |+------------------------------+-------------------+-------------------+|UK and Ireland | 21 | 20 |+------------------------------+-------------------+-------------------+|EMEA/Asia-Pacific | 9 | 8 |+------------------------------+-------------------+-------------------+|Experian | 18 | 18 |+------------------------------+-------------------+-------------------+* As previously disclosed, two businesses have been treated as discontinuingfrom 1 April 2006. These are MetaReward's incentive marketing websites whichhave been closed and large scale UK account processing, where Experian hasannounced its phased withdrawal by Autumn 2009# Experian is reporting in US dollars In the five months to 31 August 2006, Experian grew its sales from continuingactivities by 18% at constant exchange rates. Organic growth was 7% with thebalance from acquisitions. By geography, Experian's three regions all showed 7% organic sales growth. Thisperformance illustrates the benefits of Experian's successful strategy tobroaden its portfolio of businesses by geography and by product. AmericasIn dollars, sales from continuing activities in the five months to 31 August2006 increased by 20% in total. Organic growth was 7% in the period withcorporate acquisitions, largely in Interactive, generating the remaining 13%. As expected, sales in Credit Services excluding acquisitions were in line withlast year, a pleasing performance against a period where the comparatives werevery strong (H1 2005/6: +18%). Sales of products used in account acquisition(profiles and prescreen) were weaker but this was offset by good growth in riskmanagement, collections, recovery and account retention products. Sales ofDecision Analytics grew strongly, reflecting a recent contract win with Bank ofAmerica and continued strength in fraud prevention products. Sales in Marketing Solutions were marginally down year-on-year, with thecontinuing trend of strong growth in email marketing and research servicesoffset by weakness in consumer marketing data and list processing. Organicgrowth in Interactive was in excess of 20%, with particular strength in ConsumerDirect. UK and IrelandIn the five months to 31 August 2006, sales from continuing activities increasedby 20% in total at constant exchange rates. Organic growth continued at 7% inthe period despite a difficult consumer environment. The contribution fromacquisitions, largely ClarityBlue, was 13%. Excluding acquisitions, there were solid performances from Credit Services,Decision Analytics and Marketing Solutions, with particular success in fraudprevention and in the telecommunications and public sectors. Interactive salesmore than trebled in the period. EMEA/Asia-PacificIn the five months to 31 August 2006, sales from continuing activities increasedby 8% in total at constant exchange rates, of which organic growth was 7%. Therewas particular strength in Decision Analytics, especially in Southern andEastern Europe. Sales in the French transaction processing business, whichaccounted for about half of revenue in the period, were marginally ahead of lastyear. Future announcementsExperian will announce its Interim Results on 21 November 2006. Enquiries ExperianPaul Brooks Chief Financial Officer 020 7495 0070Fay Dodds Director of Investor Relations FinsburyRupert Younger 020 7251 3801Rollo Head This announcement is available on the GUS website, www.gusplc.com. All financial information is based on unaudited management accounts. Certainstatements made in this Trading Update are forward-looking statements. Suchstatements are based on current expectations and are subject to a number ofrisks and uncertainties that could cause actual events or results to differmaterially from any expected future events or results referred to in theseforward-looking statements. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity
5th Jul 20217:00 amRNSPublication of Capital Markets Day Recording
30th Jun 202111:45 amRNSResult of AGM
14th Jun 20212:30 pmRNSExercise of Warrants
7th Jun 20217:00 amRNSFinal Results
1st Feb 20217:00 amRNSTrading Update
8th Dec 20204:40 pmRNSSecond Price Monitoring Extn
8th Dec 20204:35 pmRNSPrice Monitoring Extension
4th Dec 20207:00 amRNSAppointment of Joint Broker
21st Sep 20208:00 amRNSHalf-year Report
2nd Sep 20204:15 pmRNSDirectorate Change
23rd Jul 202011:28 amRNSResult of AGM
23rd Jul 202010:48 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSFinal Results
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.